Glycemic Metrics and Patterns in People With and Without Prediabetes

NCT06921902 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-04-09

No results posted yet for this study

Summary

The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

Conditions

  • Pre Diabetes

Interventions

DEVICE

FreeStyle Libre 3

Abbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)

Sponsors & Collaborators

  • Abbott Diabetes Care

    lead INDUSTRY

Principal Investigators

  • Shridhara Karinka, PhD · Abbott Diabetes Care

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-28
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06921902 on ClinicalTrials.gov